Adverse outcome | POH MAP threshold | ||||
---|---|---|---|---|---|
Overall (n = 3185) | ≤ 55 mmHg (n = 654) | ≤ 65 mmHg (n = 1688) | ≤ 75 mmHg (n = 2674) | > 75 mmHg (n = 511) | |
30-day MACCE | |||||
Total number of patients | 2710 | 564 | 1452 | 2283 | 427 |
Patients with event (%) | 464 (17.1%) | 142 (25.2%) | 293 (20.2%) | 404 (17.7%) | 60 (14.1%) |
30-day mortality | |||||
Total number of patients | 3185 | 654 | 1688 | 2674 | 511 |
Patients with event (%) | 519 (16.3%) | 172 (26.3%) | 340 (20.1%) | 454 (17.0%) | 65 (12.7%) |
90-day mortality | |||||
Total number of patients | 3185 | 654 | 1688 | 2674 | 511 |
Patients with event (%) | 642 (20.2%) | 204 (31.2%) | 415 (24.6%) | 560 (20.9%) | 82 (16.1%) |
30-day AIS | |||||
Total number of patients | 2845 | 610 | 1540 | 2402 | 438 |
Patients with event (%) | 75 (2.6%) | 11 (1.8%) | 35 (2.3%) | 58 (2.4%) | 17 (3.9%) |
7-day AKI stage II/III | |||||
Total number of patients | 2269 | 395 | 1114 | 1880 | 389 |
Patients with event (%) | 214 (9.4%) | 60 (15.2%) | 130 (11.7%) | 194 (10.3%) | 20 (5.1%) |
30-day AMI | |||||
Total number of patients | 3013 | 602 | 1583 | 2519 | 494 |
Patients with event (%) | 37 (1.2%) | 8 (1.3%) | 24 (1.5%) | 33 (1.3%) | 4 (0.8%) |
30-day readmission | |||||
Total number of patients | 2702 | 485 | 1375 | 2258 | 444 |
Patients with event (%) | 505 (18.7%) | 92 (19.0%) | 271 (19.7%) | 430 (19.0%) | 75 (16.9%) |
7-day CRRT/dialysis | |||||
Total number of patients | 3046 | 608 | 1591 | 2553 | 493 |
Patients with event (%) | 42 (1.4%) | 20 (3.3%) | 30 (1.9%) | 39 (1.5%) | 3 (0.6%) |